General Wasting: General Research
- Research in Anti-Lipo Therapy Headlines AIDS Confab (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Moderate Weight Loss Increasingly Common for HIVers on HAART (September 1, 2005)
Wasting syndrome may be on the decline, but moderate weight loss -- of 5% or more -- has increased steadily since 1995, and appears unrelated to lipodystrophy.
From aidsmap.com
- Rosiglitazone Linked to Benign Tumors in Man With Lipodystrophy (August 17, 2004)
A case report ties the use of rosiglitazone, an experimental treatment for lipodystrophy-related fat loss, to the development of lipomas in one HIV-infected person.
From aidsmap.com
- Rosiglitazone Reduces Lipoatrophy, Hyperinsulinemia in HIV-Infected Patients, Study Finds (May 19, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Predicting Lipoatrophy After Treatment Initiation (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Improvement in Lipoatrophy Associated With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study (January 15, 2004)
When people who had developed lipoatrohpy while taking d4T (stavudine, Zerit) switched to abacavir (Ziagen) or AZT (zidovudine, Retrovir), their condition improved.
In Clinical Infectious Diseases
- In HIV Patients With Lipoatrophy, Antioxidants Lead to Only Modest Improvement in LDL Cholesterol (August 15, 2003)
From aidsmap.com
- FRAM Study Finds a Lack of Association Between Lipoatrophy and Central Fat Gain (July 15, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Current Research on the Mechanisms Causing Lipoatrophy and Potential Treatments (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Rosiglitazone May Be Effective in Increasing Body Fat in Patients With Fat Wasting (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Substituting AZT or Abacavir for d4T in Patients With Lipoatrophy (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Studies Examine Switching Off d4T to Reverse Lipoatrophy (February 26, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Serostim Study Initiated (Spring 2001)
In CRIA Update, from AIDS Community Research Initiative of America
- Thalidomide Pharmacokinetics, Safety and Effect on HIV Viral Load and Immune Parameters (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Hormones and Body Composition (July 12, 2000)
In The XIII International AIDS Conference, from TheBodyPRO.com
- Exercise and HIV Wasting: From the Laboratory to the Clinic (July 2000)
In Body Positive, from Body Positive
- The Use of Testosterone in AIDS Wasting Syndrome (May 3, 1999)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Changing Face of Malnutrition and HIV (April 22-25, 1999)
In The 3rd International Conference on Nutrition and HIV Infection, from TheBodyPRO.com
- Treating HIV-Associated Weight Loss and Wasting (April 22-25, 1999)
In The 3rd International Conference on Nutrition and HIV Infection, from TheBodyPRO.com
- Anabolic Steroids, Exercise and Wasting (April 1999)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- The Effects of Oxandralone on Body Weight and Composition in Patients With HIV-Associated Weight Loss (July 2, 1998)
In The 12th International AIDS Conference, from TheBodyPRO.com
|
Advertisement
|
Email
Glossary
